Abnormal Involuntary Movement Scale Clinical Classification

2020 ◽  
Author(s):  
Keyword(s):  
Involuntary Movement ◽  
Clinical Classification ◽  
Abnormal Involuntary Movement Scale

Abnormal Involuntary Movement Scale

2021 ◽  
pp. 22-22
Author(s):  
Maureen Early ◽  
Logan Wink ◽  
Craig A. Erickson ◽  
Christopher J. McDougle
Keyword(s):  
Involuntary Movement ◽  
Abnormal Involuntary Movement Scale

Abnormal Involuntary Movement Scale

2013 ◽  
pp. 18-18 ◽  
Author(s):  
Maureen Early ◽  
Logan Wink ◽  
Craig Erickson ◽  
Christopher J. McDougle
Keyword(s):  
Involuntary Movement ◽  
Abnormal Involuntary Movement Scale

Revisiting the Abnormal Involuntary Movement Scale

2018 ◽  
Vol 79 (3) ◽  
Author(s):  
John M. Kane ◽  
Christoph U. Correll ◽  
Andrew A. Nierenberg ◽  
Stanley N. Caroff ◽  
Martha Sajatovic ◽  
...  
Keyword(s):  
Involuntary Movement ◽  
Abnormal Involuntary Movement Scale

scholarly journals One patient with schizophrenia showed reduced drug-induced extrapyramidal symptoms as a result of an alternative regimen of treatment with paliperidone 3 and 6 mg every other day

2017 ◽  
Vol 5 ◽  
pp. 2050313X1774283 ◽  
Author(s):  
Hidenobu Suzuki ◽  
Hiroyuki Hibino ◽  
Yuichi Inoue ◽  
Hideo Matsumoto ◽  
Katsunaka Mikami
Keyword(s):  
Adverse Effects ◽  
Scale Score ◽  
Clinical Symptoms ◽  
Involuntary Movement ◽  
Maintenance Phase ◽  
Extrapyramidal Symptoms ◽  
Drug Induced ◽  
Extrapyramidal Syndrome ◽  
Abnormal Involuntary Movement Scale ◽  
Alternative Regimen

Background: Schizophrenia is a chronic disease that requires long-term management with antipsychotics. Antipsychotic drugs are given by tapering their dose, extending the dosing interval, and so on, as part of a treatment strategy to minimize the adverse effects while at the same time maintaining efficacy. Methods: We report the case of one patient with schizophrenia in whom the clinical symptoms were alleviated after treatment with 6 mg paliperidone. However, the patient developed extrapyramidal syndrome, for which 3 and 6 mg paliperidone were administered alternately every other day. Extrapyramidal syndrome was assessed using the Drug-Induced Extrapyramidal Symptoms Scale, Abnormal Involuntary Movement Scale, or Barnes Akathisia Scale. Results: There was improvement in Drug-Induced Extrapyramidal Symptoms Scale score and Abnormal Involuntary Movement Scale score. However, there was almost no change in the Positive and Negative Syndrome Scale total score, positive score, negative score, or general score. Conclusion: The results indicate the possibility of lessened adverse effects as a result of an alternative regimen of treatment with paliperidone 3 and 6 mg every other day in the maintenance phase.

Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): Cross-scale comparison in assessing tardive dyskinesia

2005 ◽  
Vol 77 (2-3) ◽  
pp. 119-128 ◽  
Author(s):  
Georges M. Gharabawi ◽  
Cynthia A. Bossie ◽  
Robert A. Lasser ◽  
Ibrahim Turkoz ◽  
Stephen Rodriguez ◽  
...  
Keyword(s):  
Tardive Dyskinesia ◽  
Rating Scale ◽  
Extrapyramidal Symptom ◽  
Involuntary Movement ◽  
Abnormal Involuntary Movement Scale ◽  
Symptom Rating
Sign in / Sign up

Export Citation Format

Share Document